Risk for schizophrenia--broadening the concepts, pushing back the boundaries

scientific article

Risk for schizophrenia--broadening the concepts, pushing back the boundaries is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.SCHRES.2005.05.027
P698PubMed publication ID16005613

P50authorMary CannonQ18719324
P2093author name stringMary Catherine Clarke
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)5-13
P577publication date2005-11-01
P1433published inSchizophrenia ResearchQ7431607
P1476titleRisk for schizophrenia--broadening the concepts, pushing back the boundaries
P478volume79

Reverse relations

cites work (P2860)
Q37980010An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model.
Q42872711Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.
Q37001100Childhood trauma and psychotic disorders: a systematic, critical review of the evidence.
Q37319453Childhood trauma, PTSD, and psychosis: Findings from a highly traumatized, minority sample.
Q30477667Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood
Q37304289Decanalization mediating gene-environment interactions in schizophrenia and other psychiatric disorders with neurodevelopmental etiology.
Q48263254Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development
Q24652697Epigenetic mediation of environmental influences in major psychotic disorders
Q37180961Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort
Q30477639Evaluation of developmental neurotoxicity: some important issues focused on neurobehavioral development
Q33773196Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia
Q30447546Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia
Q24643775Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions
Q34407170Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models.
Q35390447Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies.
Q36287179Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis
Q36148572Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia.
Q47587674Negative symptoms of psychosis: A life course approach and implications for prevention and treatment
Q22252797Neighbourhood variation in the incidence of psychotic disorders in Southeast London
Q38861349Prevalence, impact and cultural context of psychotic experiences among ethnic minority youth
Q34953640Safety assessment of the pyridoindole derivative SMe1EC2: developmental neurotoxicity study in rats
Q33932520Schizophrenia: current concepts and approaches to patient care
Q35797941The Danish High Risk and Resilience Study--VIA 7--a cohort study of 520 7-year-old children born of parents diagnosed with either schizophrenia, bipolar disorder or neither of these two mental disorders
Q30501563The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development
Q51750311The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.
Q34659000The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.
Q28303485The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?
Q30470162The nuclear factor-κB inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acid-induced immune response in pregnant rats and the behavioral defects of their adult offspring
Q39927000The role of vulnerability factors in individuals with an at-risk mental state of psychosis
Q37022580Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention
Q35865658Wellbeing and resilience: mechanisms of transmission of health and risk in parents with complex mental health problems and their offspring--The WARM Study